Table 3
Incremental lung cancer-specific survival between low-dose computed tomography screening and control arm, by stage and years survived from diagnosis of non-small-cell lung cancer, Cancer Risk Management Model-Lung Cancer (CRMM-LC) and National Lung Screening Trial (NLST)
| Stage | Years survived lung cancer | |||||||
|---|---|---|---|---|---|---|---|---|
| 0 | 1 | 2 | 3 | 4 | 5 | 6 | 7 | |
| Survival improvement due to screening (%) | ||||||||
| I | ||||||||
| CRMM-LC | 0 | 6 | 9 | 9 | 9 | 9 | 9 | 9 |
| NLST | 0 | 8 | 10 | 11 | 8 | 8 | 13 | 9 |
| II | ||||||||
| CRMM-LC | 0 | 4 | 3 | 1 | 1 | 1 | 1 | 1 |
| NLST | 0 | 8 | 10 | 10 | 0 | 0 | -3 | -3 |
| III | ||||||||
| CRMM-LC | 0 | 6 | 5 | 0 | 0 | 0 | 1 | 1 |
| NLST | 0 | 0 | 6 | 0 | 0 | 0 | 0 | 4 |
| IV | ||||||||
| CRMM-LC | 0 | 4 | 0 | -1 | -1 | -1 | -1 | -1 |
| NLST | 0 | 2 | 2 | 1 | 1 | 3 | 2 | 1 |
Report a problem on this page
Is something not working? Is there information outdated? Can't find what you're looking for?
Please contact us and let us know how we can help you.
- Date modified: